369 related articles for article (PubMed ID: 17236635)
1. The effect of desflurane on rocuronium onset, clinical duration and maintenance requirements.
Stout RG; Gan TJ; Glass PS; Silverman DG; Brull SJ
Acta Anaesthesiol Belg; 2006; 57(4):349-53. PubMed ID: 17236635
[TBL] [Abstract][Full Text] [Related]
2. Neuromuscular blocking effects of rocuronium during desflurane, isoflurane, and sevoflurane anaesthesia.
Wulf H; Ledowski T; Linstedt U; Proppe D; Sitzlack D
Can J Anaesth; 1998 Jun; 45(6):526-32. PubMed ID: 9669005
[TBL] [Abstract][Full Text] [Related]
3. Intubating conditions and blockade after mivacurium, rocuronium and their combination in young and elderly adults.
Motamed C; Donati F
Can J Anaesth; 2000 Mar; 47(3):225-31. PubMed ID: 10730732
[TBL] [Abstract][Full Text] [Related]
4. Rocuronium potency and recovery characteristics during steady-state desflurane, sevoflurane, isoflurane or propofol anaesthesia.
Bock M; Klippel K; Nitsche B; Bach A; Martin E; Motsch J
Br J Anaesth; 2000 Jan; 84(1):43-7. PubMed ID: 10740546
[TBL] [Abstract][Full Text] [Related]
5. Neuromuscular recovery following rocuronium bromide single dose in infants.
Rapp HJ; Altenmueller CA; Waschke C
Paediatr Anaesth; 2004 Apr; 14(4):329-35. PubMed ID: 15078379
[TBL] [Abstract][Full Text] [Related]
6. Rocuronium 0.3 mg x kg-1 (ED95) induces a normal peak effect but an altered time course of neuromuscular block in patients with Duchenne's muscular dystrophy.
Muenster T; Schmidt J; Wick S; Forst J; Schmitt HJ
Paediatr Anaesth; 2006 Aug; 16(8):840-5. PubMed ID: 16884467
[TBL] [Abstract][Full Text] [Related]
7. Rocuronium pharmacokinetic-pharmacodynamic relationship under stable propofol or isoflurane anesthesia.
Dragne A; Varin F; Plaud B; Donati F
Can J Anaesth; 2002 Apr; 49(4):353-60. PubMed ID: 11927473
[TBL] [Abstract][Full Text] [Related]
8. Reversal of rocuronium with edrophonium during propofol versus sevoflurane anesthesia.
Zhou TJ; Chiu JW; White PF; Forestner JE; Murphy MT
Acta Anaesthesiol Scand; 2001 Feb; 45(2):246-9. PubMed ID: 11167172
[TBL] [Abstract][Full Text] [Related]
9. Pharmacodynamics of rocuronium 0.3 mg kg(-1) in adult patients with and without renal failure.
Robertson EN; Driessen JJ; Vogt M; De Boer H; Scheffer GJ
Eur J Anaesthesiol; 2005 Dec; 22(12):929-32. PubMed ID: 16318664
[TBL] [Abstract][Full Text] [Related]
10. Rocuronium duration of action under sevoflurane, desflurane or propofol anaesthesia.
Maidatsi PG; Zaralidou AT; Gorgias NK; Amaniti EN; Karakoulas KA; Giala MM
Eur J Anaesthesiol; 2004 Oct; 21(10):781-6. PubMed ID: 15678732
[TBL] [Abstract][Full Text] [Related]
11. Quantitation of the interaction of rocuronium bromide with etomidate, fentanyl, midazolam, propofol, thiopentone, and isoflurane using closed-loop feedback control of infusion of rocuronium.
Olkkola KT; Tammisto T
Eur J Anaesthesiol Suppl; 1994; 9():99-100. PubMed ID: 7925218
[TBL] [Abstract][Full Text] [Related]
12. Recovery of neuromuscular function after a combination of mivacurium and rocuronium.
Stout RG; Shine TS; Silverman DG; Brull SJ
Yale J Biol Med; 2004 Sep; 77(5-6):149-54. PubMed ID: 15989744
[TBL] [Abstract][Full Text] [Related]
13. Reversal of neuromuscular blockade by sugammadex after continuous infusion of rocuronium in patients randomized to sevoflurane or propofol maintenance anesthesia.
Rex C; Wagner S; Spies C; Scholz J; Rietbergen H; Heeringa M; Wulf H
Anesthesiology; 2009 Jul; 111(1):30-5. PubMed ID: 19512873
[TBL] [Abstract][Full Text] [Related]
14. The effect of residual neuromuscular blockade on the speed of reversal with sugammadex.
White PF; Tufanogullari B; Sacan O; Pavlin EG; Viegas OJ; Minkowitz HS; Hudson ME
Anesth Analg; 2009 Mar; 108(3):846-51. PubMed ID: 19224792
[TBL] [Abstract][Full Text] [Related]
15. Neuromuscular effects of rocuronium during sevoflurane, isoflurane, and intravenous anesthesia.
Lowry DW; Mirakhur RK; McCarthy GJ; Carroll MT; McCourt KC
Anesth Analg; 1998 Oct; 87(4):936-40. PubMed ID: 9768798
[TBL] [Abstract][Full Text] [Related]
16. Potency and time course of action of rocuronium during desflurane and isoflurane anaesthesia.
Kumar N; Mirakhur RK; Symington MJ; McCarthy GJ
Br J Anaesth; 1996 Oct; 77(4):488-91. PubMed ID: 8942333
[TBL] [Abstract][Full Text] [Related]
17. Should dosing of rocuronium in obese patients be based on ideal or corrected body weight?
Meyhoff CS; Lund J; Jenstrup MT; Claudius C; Sørensen AM; Viby-Mogensen J; Rasmussen LS
Anesth Analg; 2009 Sep; 109(3):787-92. PubMed ID: 19690247
[TBL] [Abstract][Full Text] [Related]
18. Desflurane reduces the effective therapeutic infusion rate (ETI) of cisatracurium more than isoflurane, sevoflurane, or propofol.
Hemmerling TM; Schuettler J; Schwilden H
Can J Anaesth; 2001 Jun; 48(6):532-7. PubMed ID: 11444446
[TBL] [Abstract][Full Text] [Related]
19. Interactions of volatile anaesthetics with rocuronium bromide in perspective.
Agoston S
Eur J Anaesthesiol Suppl; 1994; 9():107-11. PubMed ID: 7925200
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the influence of desflurane nitrous oxide anesthesia to propofol nitrous oxide anesthesia on rocuronium bromide induced neuromuscular block.
Verhaeghe B; Vanacker B; Van de Velde M; Vandermeersch E
Acta Anaesthesiol Belg; 2001; 52(3):301-5. PubMed ID: 11732388
[No Abstract] [Full Text] [Related]
[Next] [New Search]
